Dalumingo, Resulne .
HRN: 24-41-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2024
CLINDAMYCIN 300MG (CAP)
02/20/2024
02/26/2024
IV
300mg
Q8
S/P LTCS With IUD Insertion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes